Select Page

Latest News

December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

December 15, 2021
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member

December 9, 2021
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom

November 30, 2021
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises

November 24, 2021
Rapid Dose Therapeutics Completes Milestone One Million QuickStrip™ Units Shipped to a Single Company

November 9, 2021
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis

October 1, 2021
Rapid Dose Therapeutics Receives Cannabis Sales License from Health Canada

September 28, 2021
Rapid Dose Therapeutics Welcomed Premier Doug Ford to Tour Burlington Facility

September 15, 2021
Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones

August 26, 2021
Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

1 2 3 4 5 6 7 8 9 10 11